ConductScience.org, home

Paper36923538

FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.

Chen X and 11 others. Theranostics, 2023. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC. Papers, record 36923538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923538

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.
PubMed
Journal
Theranostics
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
3.19
iCite
Revised in PubMed
2023-04-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXilang
2Chen JJie
3Feng WWeibo
4Huang WWenjie
5Wang GGuodong
6Sun MMengyu
7Luo XXiangyuan
8Wang YYijun
9Nie YYongzhan
10Fan DDaiming
11Wu KKaichun
12Xia LLimin

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptor, Fibroblast Growth Factor, Type 4Major topic
Colorectal NeoplasmsMajor topic
Humans
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Cell Proliferation
Neoplasm Metastasis
DNA-Binding Proteins
Transcription Factors
Fibroblast Growth Factors

Source PubMed

Download CSV of topics

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133456563CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.Theranostics2021https://conductscience.org/library/papers/33456563PubMed
221552992Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.Invest New Drugs2012https://conductscience.org/library/papers/21552992PubMed
327932483Roles and regulations of the ETS transcription factor ELF4/MEF.J Mol Cell Biol2017https://conductscience.org/library/papers/27932483PubMed
426921333Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer.Cancer Res2016https://conductscience.org/library/papers/26921333PubMed
533334065Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.Cancers (Basel)2020https://conductscience.org/library/papers/33334065PubMed
624874735Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer.Cell Death Dis2014https://conductscience.org/library/papers/24874735PubMed
718593907Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.Cancer Res2008https://conductscience.org/library/papers/18593907PubMed
831575540Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.Cancer Discov2019https://conductscience.org/library/papers/31575540PubMed
919809159Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.J Clin Invest2009https://conductscience.org/library/papers/19809159PubMed
1033713299Tirbanibulin: First Approval.Drugs2021https://conductscience.org/library/papers/33713299PubMed
1136209117Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/36209117PubMed
1223943801FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.Cancer Res2013https://conductscience.org/library/papers/23943801PubMed
1325854696FGF19 promotes progression of prostate cancer.Prostate2015https://conductscience.org/library/papers/25854696PubMed
1421852023Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.Eur J Med Chem2011https://conductscience.org/library/papers/21852023PubMed
1536352028PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.Br J Cancer2023https://conductscience.org/library/papers/36352028PubMed
1636598638Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis.Cell Oncol (Dordr)2023https://conductscience.org/library/papers/36598638PubMed
1719247306The FGF family: biology, pathophysiology and therapy.Nat Rev Drug Discov2009https://conductscience.org/library/papers/19247306PubMed
1833591350Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.JAMA2021https://conductscience.org/library/papers/33591350PubMed
1921747170Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.J Clin Invest2011https://conductscience.org/library/papers/21747170PubMed
2030070748Role of fibroblast growth factor receptor 4 in cancer.Cancer Sci2018https://conductscience.org/library/papers/30070748PubMed

See all 60 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42737619Dual Targeting of FGFR4 and PI3K-mTOR Suppresses Tumor-Associated Phenotypes in Pancreatic Ductal Adenocarcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/42737619PubMed
42724722Prognostic and clinicopathologic significance of FGFR mRNA and protein overexpression in colorectal cancer: a systematic review and meta-analysis.Transl Cancer Res2026https://conductscience.org/library/papers/42724722PubMed
42633326Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42633326PubMed
42463639Dual-faced metabolic reprogramming powers proliferation: FGF21 drives lung squamous carcinoma progression via CaMKII-DRP1-mediated mitochondrial fission.Cell Death Dis2026https://conductscience.org/library/papers/42463639PubMed
42180975Construction of a prognostic risk model based on colorectal cancer-specific ferroptosis genes and preliminary validation of FGFR4.Transl Cancer Res2026https://conductscience.org/library/papers/42180975PubMed
42149884In-silico prediction of multi‑target mechanisms of Pinellia ternata phytochemicals in lung cancer: Evidence from a graph‑attention‑guided virtual screening and multi‑scale simulations.PLoS One2026https://conductscience.org/library/papers/42149884PubMed
41918035Integrative genomic profiling of iron homeostasis predicts clinical outcomes and identifies HAMP/hepcidin as a therapeutic target in colorectal cancer.Cell Biosci2026https://conductscience.org/library/papers/41918035PubMed
41821016Targeting the FGF19/FGFR4 positive feedback loop to disrupt ERK-mediated tumor progression in head and neck cancer.J Transl Med2026https://conductscience.org/library/papers/41821016PubMed
41789601lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer.Int J Oncol2026https://conductscience.org/library/papers/41789601PubMed
41681889Targeting Colorectal Cancer Stem Cells Through Inhibition of the Fibroblast Growth Factor Receptor 4 Pathway with a Novel Antibody.Cancers (Basel)2026https://conductscience.org/library/papers/41681889PubMed
41666187Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma.PLoS One2026https://conductscience.org/library/papers/41666187PubMed
41631414Colorectal cancer-derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver.Mol Oncol2026https://conductscience.org/library/papers/41631414PubMed
41551579Mechanistic study of glutamine metabolic reprogramming driving non-small cell lung cancer progression via the FGF17-FGFR4 axis mediating epithelial-mesenchymal transition.Front Mol Biosci2025https://conductscience.org/library/papers/41551579PubMed
41407838Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1.NPJ Precis Oncol2025https://conductscience.org/library/papers/41407838PubMed
41328353FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities.Theranostics2026https://conductscience.org/library/papers/41328353PubMed
41287970ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer.J Cell Physiol2025https://conductscience.org/library/papers/41287970PubMed
41210688Isoliquiritigenin inhibits colorectal cancer progression by targeting the FGFR4/FASN mediated lipid metabolism pathway.J Cancer2025https://conductscience.org/library/papers/41210688PubMed
41179295RAD23B Promotes Colorectal Cancer Metastasis via the Talin1/Integrin/PI3K/AKT/MMP9 Axis.Oncol Res2025https://conductscience.org/library/papers/41179295PubMed
41074024Integrating the secretome and interactome to identify novel biomarkers and therapeutic targets in colorectal cancer.Cell Commun Signal2025https://conductscience.org/library/papers/41074024PubMed
41002393The Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer.Cells2025https://conductscience.org/library/papers/41002393PubMed

See all 32 cited byDownload CSV of cited by

Genes57

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDX21045PubTator's text mininghttps://conductscience.org/library/genes/1045NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
EHF26298PubTator's text mininghttps://conductscience.org/library/genes/26298NCBI Gene
ELF11997PubTator's text mininghttps://conductscience.org/library/genes/1997NCBI Gene
ELF21998PubTator's text mininghttps://conductscience.org/library/genes/1998NCBI Gene
ELF31999PubTator's text mininghttps://conductscience.org/library/genes/1999NCBI Gene
ELF42000PubTator's text mininghttps://conductscience.org/library/genes/2000NCBI Gene
ELF52001PubTator's text mininghttps://conductscience.org/library/genes/2001NCBI Gene
ELK12002PubTator's text mininghttps://conductscience.org/library/genes/2002NCBI Gene
ELK32004PubTator's text mininghttps://conductscience.org/library/genes/2004NCBI Gene
ELK42005PubTator's text mininghttps://conductscience.org/library/genes/2005NCBI Gene
EPHB22048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
ERF2077PubTator's text mininghttps://conductscience.org/library/genes/2077NCBI Gene
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
ETS12113PubTator's text mininghttps://conductscience.org/library/genes/2113NCBI Gene
ETS22114PubTator's text mininghttps://conductscience.org/library/genes/2114NCBI Gene
ETV12115PubTator's text mininghttps://conductscience.org/library/genes/2115NCBI Gene
ETV22116PubTator's text mininghttps://conductscience.org/library/genes/2116NCBI Gene

See all 57 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36923538

GET https://conductscience.org/api/papers/v1/36923538/references?page=2